Description
This product utilizes γδ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1C1R22-24). We employs the Lentivirus (T7-Cy3-IL-17-SmaI) vector components and the SynExpress system of the single base pair Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1C1R22-24
Species Reactivity
Human
Cell Source
γδ T cells
Sensor Gene
Cy3
Promoter
T7
Effector Gene
IL-17
Insertion Sites
SmaI
Gene Modification
Knock-in
Modification Domain
Single base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.89
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.